<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">35484142</PMID><DateCompleted><Year>2022</Year><Month>05</Month><Day>02</Day></DateCompleted><DateRevised><Year>2023</Year><Month>04</Month><Day>09</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2041-1723</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Apr</Month><Day>28</Day></PubDate></JournalIssue><Title>Nature communications</Title><ISOAbbreviation>Nat Commun</ISOAbbreviation></Journal><ArticleTitle>Heterozygous frameshift variants in HNRNPA2B1 cause early-onset oculopharyngeal muscular dystrophy.</ArticleTitle><Pagination><StartPage>2306</StartPage><MedlinePgn>2306</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">2306</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41467-022-30015-1</ELocationID><Abstract><AbstractText>Missense variants in RNA-binding proteins (RBPs) underlie a spectrum of disease phenotypes, including amyotrophic lateral sclerosis, frontotemporal dementia, and inclusion body myopathy. Here, we present ten independent families with a severe, progressive muscular dystrophy, reminiscent of oculopharyngeal muscular dystrophy (OPMD) but of much earlier onset, caused by heterozygous frameshift variants in the RBP hnRNPA2/B1. All disease-causing frameshift mutations abolish the native stop codon and extend the reading frame, creating novel transcripts that escape nonsense-mediated decay and are translated to produce hnRNPA2/B1 protein with the same neomorphic C-terminal sequence. In contrast to previously reported disease-causing missense variants in HNRNPA2B1, these frameshift variants do not increase the propensity of hnRNPA2 protein to fibrillize. Rather, the frameshift variants have reduced affinity for the nuclear import receptor karyopherin &#x3b2;2, resulting in cytoplasmic accumulation of hnRNPA2 protein in cells and in animal models that recapitulate the human pathology. Thus, we expand the phenotypes associated with HNRNPA2B1 to include an early-onset form of OPMD caused by frameshift variants that alter its nucleocytoplasmic transport dynamics.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Kim</LastName><ForeName>Hong Joo</ForeName><Initials>HJ</Initials><Identifier Source="ORCID">0000-0002-9157-1612</Identifier><AffiliationInfo><Affiliation>Department of Cell and Molecular Biology, St. Jude Children's Research Hospital, Memphis, TN, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Mohassel</LastName><ForeName>Payam</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0001-5313-9514</Identifier><AffiliationInfo><Affiliation>National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Donkervoort</LastName><ForeName>Sandra</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Lin</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Biochemistry &amp; Biophysics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Biology, Thomas Jefferson University, Philadelphia, PA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>O'Donovan</LastName><ForeName>Kevin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Cell and Molecular Biology, St. Jude Children's Research Hospital, Memphis, TN, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Coughlin</LastName><ForeName>Maura</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Cell and Molecular Biology, St. Jude Children's Research Hospital, Memphis, TN, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lornage</LastName><ForeName>Xaviere</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>D&#xe9;partement M&#xe9;decine Translationnelle et Neurog&#xe9;n&#xe9;tique, Institut de G&#xe9;n&#xe9;tique et de Biologie Mol&#xe9;culaire et Cellulaire, Institut National de la Sant&#xe9; et de la Recherche M&#xe9;dicale U1258, Centre National de la Recherche Scientifique UMR7104, Universit&#xe9; de Strasbourg, Illkirch, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Foulds</LastName><ForeName>Nicola</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Wessex Clinical Genetics Services, Princess Anne Hospital, Academic Unit of Human Development and Health, Faculty of Medicine, University of Southampton, Southampton, England.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hammans</LastName><ForeName>Simon R</ForeName><Initials>SR</Initials><AffiliationInfo><Affiliation>Wessex Neurological Centre, University Hospital Southampton, Southampton, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Foley</LastName><ForeName>A Reghan</ForeName><Initials>AR</Initials><AffiliationInfo><Affiliation>National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fare</LastName><ForeName>Charlotte M</ForeName><Initials>CM</Initials><Identifier Source="ORCID">0000-0003-0394-6435</Identifier><AffiliationInfo><Affiliation>Department of Biochemistry &amp; Biophysics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ford</LastName><ForeName>Alice F</ForeName><Initials>AF</Initials><AffiliationInfo><Affiliation>Department of Biochemistry &amp; Biophysics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ogasawara</LastName><ForeName>Masashi</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neuromuscular Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry (NCNP), 4-1-1 Ogawahigashi, Kodaira, Tokyo, 187-8502, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical Genome Center, NCNP, Kodaira, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sato</LastName><ForeName>Aki</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurology, Niigata City General Hospital, Niigata, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Iida</LastName><ForeName>Aritoshi</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-7538-1651</Identifier><AffiliationInfo><Affiliation>Medical Genome Center, NCNP, Kodaira, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Munot</LastName><ForeName>Pinki</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>The Dubowitz Neuromuscular Centre, NIHR Great Ormond Street Hospital Biomedical Research Centre, Great Ormond Street Institute of Child Health, University College London, &amp; Great Ormond Street Hospital Trust, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ambegaonkar</LastName><ForeName>Gautam</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Paediatric Neurology, Cambridge University Hospital NHS Trust, Addenbrookes Hospital, Cambridge, CB2 0QQ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Phadke</LastName><ForeName>Rahul</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Division of Neuropathology, University College London Hospitals NHS Foundation Trust National Hospital for Neurology and Neurosurgery London, UK and Division of Neuropathology, UCL Institute of Neurology, Dubowitz Neuromuscular Centre, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>O'Donovan</LastName><ForeName>Dominic G</ForeName><Initials>DG</Initials><AffiliationInfo><Affiliation>Department of Histopathology Box 235, Level 5 John Bonnett Clinical Laboratories Addenbrooke's Hospital, Cambridge, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Buchert</LastName><ForeName>Rebecca</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0001-7576-3326</Identifier><AffiliationInfo><Affiliation>Institute of Medical Genetics and Applied Genomics, University of Tuebingen, Tuebingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grimmel</LastName><ForeName>Mona</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute of Medical Genetics and Applied Genomics, University of Tuebingen, Tuebingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>T&#xf6;pf</LastName><ForeName>Ana</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>John Walton Muscular Dystrophy Research Centre, Newcastle University and Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zaharieva</LastName><ForeName>Irina T</ForeName><Initials>IT</Initials><AffiliationInfo><Affiliation>The Dubowitz Neuromuscular Centre, NIHR Great Ormond Street Hospital Biomedical Research Centre, Great Ormond Street Institute of Child Health, University College London, &amp; Great Ormond Street Hospital Trust, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brady</LastName><ForeName>Lauren</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Division of Neuromuscular &amp; Neurometabolic Disorders, Department of Pediatrics, McMaster University, Hamilton Health Sciences Centre, Hamilton, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Ying</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lloyd</LastName><ForeName>Thomas E</ForeName><Initials>TE</Initials><Identifier Source="ORCID">0000-0003-4756-3700</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Klein</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Neuropaediatrics, Development and Rehabilitation, Department of Pediatrics, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Pediatric Neurology, University Children's Hospital Basel, University of Basel, Basel, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Steinlin</LastName><ForeName>Maja</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Neuropaediatrics, Development and Rehabilitation, Department of Pediatrics, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kuster</LastName><ForeName>Alice</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurometabolism, University Hospital of Nantes, Nantes, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mercier</LastName><ForeName>Sandra</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>CHU Nantes, Service de g&#xe9;n&#xe9;tique m&#xe9;dicale, Centre de R&#xe9;f&#xe9;rence des Maladies Neuromusculaires AOC, 44000, Nantes, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Universit&#xe9; de Nantes, CNRS, INSERM, l'institut du thorax, 44000, Nantes, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marcorelles</LastName><ForeName>Pascale</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Service d'anatomopathologie, CHU Brest and EA 4685 LIEN, Universit&#xe9; de Bretagne Occidentale, Brest, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>P&#xe9;r&#xe9;on</LastName><ForeName>Yann</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>CHU de Nantes, Centre de R&#xe9;f&#xe9;rence des Maladies Neuromusculaires, Filnemus, Euro-NMD, H&#xf4;tel-Dieu, Nantes, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fleurence</LastName><ForeName>Emmanuelle</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-6717-3737</Identifier><AffiliationInfo><Affiliation>Etablissement de Sant&#xe9; pour Enfants et Adolescents de la r&#xe9;gion Nantaise, Nantes, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Manzur</LastName><ForeName>Adnan</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>The Dubowitz Neuromuscular Centre, NIHR Great Ormond Street Hospital Biomedical Research Centre, Great Ormond Street Institute of Child Health, University College London, &amp; Great Ormond Street Hospital Trust, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ennis</LastName><ForeName>Sarah</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-2648-0869</Identifier><AffiliationInfo><Affiliation>Human Genetics and Genomic Medicine, Faculty of Medicine, University of Southampton, Southampton, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Upstill-Goddard</LastName><ForeName>Rosanna</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-2666-0934</Identifier><AffiliationInfo><Affiliation>Human Genetics and Genomic Medicine, Faculty of Medicine, University of Southampton, Southampton, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bello</LastName><ForeName>Luca</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-3075-6525</Identifier><AffiliationInfo><Affiliation>Department of Neurosciences, DNS, University of Padova, Padova, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bertolin</LastName><ForeName>Cinzia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Clinical Genetics Unit, Department of Women and Children's Health, University of Padova, IRP Citt&#xe0; della Speranza, Padova, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pegoraro</LastName><ForeName>Elena</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Neurosciences, DNS, University of Padova, Padova, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Salviati</LastName><ForeName>Leonardo</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0001-5642-9963</Identifier><AffiliationInfo><Affiliation>Clinical Genetics Unit, Department of Women and Children's Health, CIR-Myo Myology Center, University of Padova, IRP Citt&#xe0; della Speranza, Padova, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>French</LastName><ForeName>Courtney E</ForeName><Initials>CE</Initials><Identifier Source="ORCID">0000-0001-7620-1544</Identifier><AffiliationInfo><Affiliation>Department of Paediatrics, University of Cambridge, Cambridge, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shatillo</LastName><ForeName>Andriy</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-3630-6880</Identifier><AffiliationInfo><Affiliation>Institute of Neurology, Psychiatry and Narcology of NAMS of Ukraine, Kharkiv, Ukraine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Raymond</LastName><ForeName>F Lucy</ForeName><Initials>FL</Initials><Identifier Source="ORCID">0000-0003-2652-3355</Identifier><AffiliationInfo><Affiliation>Cambridge Institute of Medical Research, University of Cambridge, Cambridge, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haack</LastName><ForeName>Tobias B</ForeName><Initials>TB</Initials><AffiliationInfo><Affiliation>Institute of Medical Genetics and Applied Genomics, University of Tuebingen, Tuebingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Quijano-Roy</LastName><ForeName>Susana</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Neuromuscular Unit, Pediatric Neurology and ICU Department, Raymond Poincar&#xe9; Hospital (UVSQ), AP-HP Universit&#xe9; Paris-Saclay, Garches, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>B&#xf6;hm</LastName><ForeName>Johann</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>D&#xe9;partement M&#xe9;decine Translationnelle et Neurog&#xe9;n&#xe9;tique, Institut de G&#xe9;n&#xe9;tique et de Biologie Mol&#xe9;culaire et Cellulaire, Institut National de la Sant&#xe9; et de la Recherche M&#xe9;dicale U1258, Centre National de la Recherche Scientifique UMR7104, Universit&#xe9; de Strasbourg, Illkirch, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nelson</LastName><ForeName>Isabelle</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Sorbonne Universit&#xe9;, INSERM, Centre of Research in Myology, UMRS974, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stojkovic</LastName><ForeName>Tanya</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>APHP, Centre de R&#xe9;f&#xe9;rence des Maladies Neuromusculaires Nord/Est/Ile de France, Institut de Myologie, Sorbonne Universit&#xe9;, H&#xf4;pital Piti&#xe9;-Salp&#xea;tri&#xe8;re, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Evangelista</LastName><ForeName>Teresinha</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Unit&#xe9; de Morphologie Neuromusculaire, Institut de Myologie, Sorbonne Universit&#xe9;, H&#xf4;pital Piti&#xe9;-Salp&#xea;tri&#xe8;re, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Straub</LastName><ForeName>Volker</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0001-9046-3540</Identifier><AffiliationInfo><Affiliation>John Walton Muscular Dystrophy Research Centre, Newcastle University and Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Romero</LastName><ForeName>Norma B</ForeName><Initials>NB</Initials><AffiliationInfo><Affiliation>APHP, Centre de R&#xe9;f&#xe9;rence des Maladies Neuromusculaires Nord/Est/Ile de France, Institut de Myologie, Sorbonne Universit&#xe9;, H&#xf4;pital Piti&#xe9;-Salp&#xea;tri&#xe8;re, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Unit&#xe9; de Morphologie Neuromusculaire, Institut de Myologie, Sorbonne Universit&#xe9;, H&#xf4;pital Piti&#xe9;-Salp&#xea;tri&#xe8;re, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Laporte</LastName><ForeName>Jocelyn</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0001-8256-5862</Identifier><AffiliationInfo><Affiliation>D&#xe9;partement M&#xe9;decine Translationnelle et Neurog&#xe9;n&#xe9;tique, Institut de G&#xe9;n&#xe9;tique et de Biologie Mol&#xe9;culaire et Cellulaire, Institut National de la Sant&#xe9; et de la Recherche M&#xe9;dicale U1258, Centre National de la Recherche Scientifique UMR7104, Universit&#xe9; de Strasbourg, Illkirch, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Muntoni</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>The Dubowitz Neuromuscular Centre, NIHR Great Ormond Street Hospital Biomedical Research Centre, Great Ormond Street Institute of Child Health, University College London, &amp; Great Ormond Street Hospital Trust, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nishino</LastName><ForeName>Ichizo</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0001-9452-112X</Identifier><AffiliationInfo><Affiliation>Department of Neuromuscular Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry (NCNP), 4-1-1 Ogawahigashi, Kodaira, Tokyo, 187-8502, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical Genome Center, NCNP, Kodaira, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tarnopolsky</LastName><ForeName>Mark A</ForeName><Initials>MA</Initials><Identifier Source="ORCID">0000-0003-0312-3746</Identifier><AffiliationInfo><Affiliation>Division of Neuromuscular &amp; Neurometabolic Disorders, Department of Pediatrics, McMaster University, Hamilton Health Sciences Centre, Hamilton, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shorter</LastName><ForeName>James</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Biochemistry &amp; Biophysics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>B&#xf6;nnemann</LastName><ForeName>Carsten G</ForeName><Initials>CG</Initials><Identifier Source="ORCID">0000-0002-5930-2324</Identifier><AffiliationInfo><Affiliation>National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, United States. carsten.bonnemann@nih.gov.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Taylor</LastName><ForeName>J Paul</ForeName><Initials>JP</Initials><Identifier Source="ORCID">0000-0002-5794-0349</Identifier><AffiliationInfo><Affiliation>Department of Cell and Molecular Biology, St. Jude Children's Research Hospital, Memphis, TN, United States. jpaul.taylor@stjude.org.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Howard Hughes Medical Institute, Chevy Chase, MD, United States. jpaul.taylor@stjude.org.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 HG009141</GrantID><Acronym>HG</Acronym><Agency>NHGRI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>F31 NS087676</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>R35 NS097974</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UM1 HG008900</GrantID><Acronym>HG</Acronym><Agency>NHGRI NIH HHS</Agency><Country>United States</Country></Grant><Grant><Acronym>HHMI</Acronym><Agency>Howard Hughes Medical Institute</Agency><Country>United States</Country></Grant><Grant><Acronym>DH_</Acronym><Agency>Department of Health</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>T32 GM008275</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>F31 NS111870</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 GM099836</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D052060">Research Support, N.I.H., Intramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>04</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nat Commun</MedlineTA><NlmUniqueID>101528555</NlmUniqueID><ISSNLinking>2041-1723</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C502034">HNRNPA3 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D034481">Heterogeneous-Nuclear Ribonucleoprotein Group A-B</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016368" MajorTopicYN="N">Frameshift Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D034481" MajorTopicYN="N">Heterogeneous-Nuclear Ribonucleoprotein Group A-B</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006579" MajorTopicYN="N">Heterozygote</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D039141" MajorTopicYN="Y">Muscular Dystrophy, Oculopharyngeal</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>J.P.T. is a consultant for 5AM and Third Rock Ventures. J.S. is a consultant for Dewpoint Therapeutics, ADRx, Neumora, Vivid Science, and Korro Bio. M.A.T. is the founder and CEO of Exerkine and CSO for Cora Therapeutics. The remaining authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>4</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>3</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>4</Month><Day>28</Day><Hour>23</Hour><Minute>17</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>4</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>5</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35484142</ArticleId><ArticleId IdType="pmc">PMC9050844</ArticleId><ArticleId IdType="doi">10.1038/s41467-022-30015-1</ArticleId><ArticleId IdType="pii">10.1038/s41467-022-30015-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Tauber D, Tauber G, Parker R. Mechanisms and regulation of RNA condensation in RNP granule formation. Trends Biochem. Sci. 2020;45:764&#x2013;778. doi: 10.1016/j.tibs.2020.05.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tibs.2020.05.002</ArticleId><ArticleId IdType="pmc">PMC7211619</ArticleId><ArticleId IdType="pubmed">32475683</ArticleId></ArticleIdList></Reference><Reference><Citation>Gomes E, Shorter J. The molecular language of membraneless organelles. J. Biol. Chem. 2019;294:7115&#x2013;7127. doi: 10.1074/jbc.TM118.001192.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.TM118.001192</ArticleId><ArticleId IdType="pmc">PMC6509512</ArticleId><ArticleId IdType="pubmed">30045872</ArticleId></ArticleIdList></Reference><Reference><Citation>Lyon AS, Peeples WB, Rosen MK. A framework for understanding the functions of biomolecular condensates across scales. Nat. Rev. Mol. Cell Biol. 2021;22:215&#x2013;235. doi: 10.1038/s41580-020-00303-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41580-020-00303-z</ArticleId><ArticleId IdType="pmc">PMC8574987</ArticleId><ArticleId IdType="pubmed">33169001</ArticleId></ArticleIdList></Reference><Reference><Citation>Kabashi E, et al. TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. Nat. Genet. 2008;40:572&#x2013;574. doi: 10.1038/ng.132.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.132</ArticleId><ArticleId IdType="pubmed">18372902</ArticleId></ArticleIdList></Reference><Reference><Citation>Sreedharan J, et al. TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science. 2008;319:1668&#x2013;1672. doi: 10.1126/science.1154584.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1154584</ArticleId><ArticleId IdType="pmc">PMC7116650</ArticleId><ArticleId IdType="pubmed">18309045</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim HJ, et al. Mutations in prion-like domains in hnRNPA2B1 and hnRNPA1 cause multisystem proteinopathy and ALS. Nature. 2013;495:467&#x2013;473. doi: 10.1038/nature11922.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature11922</ArticleId><ArticleId IdType="pmc">PMC3756911</ArticleId><ArticleId IdType="pubmed">23455423</ArticleId></ArticleIdList></Reference><Reference><Citation>Beijer, D. et al. Characterization of HNRNPA1 mutations defines diversity in pathogenic mechanisms and clinical presentation. JCI Insight6, e148363 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8410042</ArticleId><ArticleId IdType="pubmed">34291734</ArticleId></ArticleIdList></Reference><Reference><Citation>Naruse H, et al. Molecular epidemiological study of familial amyotrophic lateral sclerosis in Japanese population by whole-exome sequencing and identification of novel HNRNPA1 mutation. Neurobiol. Aging. 2018;61:255 e9&#x2013;255 e16. doi: 10.1016/j.neurobiolaging.2017.08.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2017.08.030</ArticleId><ArticleId IdType="pubmed">29033165</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Q, et al. Whole-exome sequencing identifies a missense mutation in hnRNPA1 in a family with flail arm ALS. Neurology. 2016;87:1763&#x2013;1769. doi: 10.1212/WNL.0000000000003256.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000003256</ArticleId><ArticleId IdType="pubmed">27694260</ArticleId></ArticleIdList></Reference><Reference><Citation>Qi X, et al. Familial early-onset paget&#x2019;s disease of bone associated with a novel hnRNPA2B1 mutation. Calcif. Tissue Int. 2017;101:159&#x2013;169. doi: 10.1007/s00223-017-0269-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00223-017-0269-0</ArticleId><ArticleId IdType="pubmed">28389692</ArticleId></ArticleIdList></Reference><Reference><Citation>Berardo A, et al. HNRNPDL-related muscular dystrophy: expanding the clinical, morphological and MRI phenotypes. J. Neurol. 2019;266:2524&#x2013;2534. doi: 10.1007/s00415-019-09437-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-019-09437-3</ArticleId><ArticleId IdType="pubmed">31267206</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Y, et al. Limb girdle muscular dystrophy D3 HNRNPDL related in a Chinese family with distal muscle weakness caused by a mutation in the prion-like domain. J. Neurol. 2019;266:498&#x2013;506. doi: 10.1007/s00415-018-9165-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-018-9165-4</ArticleId><ArticleId IdType="pubmed">30604053</ArticleId></ArticleIdList></Reference><Reference><Citation>Vieira NM, et al. A defect in the RNA-processing protein HNRPDL causes limb-girdle muscular dystrophy 1G (LGMD1G) Hum. Mol. Genet. 2014;23:4103&#x2013;4110. doi: 10.1093/hmg/ddu127.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddu127</ArticleId><ArticleId IdType="pubmed">24647604</ArticleId></ArticleIdList></Reference><Reference><Citation>Straub V, Murphy A, Udd B, group, L.w.s. 229th ENMC international workshop: limb girdle muscular dystrophies&#x2014;nomenclature and reformed classification Naarden, the Netherlands, 17&#x2013;19 March 2017. Neuromuscul. Disord. 2018;28:702&#x2013;710. doi: 10.1016/j.nmd.2018.05.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nmd.2018.05.007</ArticleId><ArticleId IdType="pubmed">30055862</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwiatkowski TJ, Jr., et al. Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science. 2009;323:1205&#x2013;1208. doi: 10.1126/science.1166066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1166066</ArticleId><ArticleId IdType="pubmed">19251627</ArticleId></ArticleIdList></Reference><Reference><Citation>Vance C, et al. Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science. 2009;323:1208&#x2013;1211. doi: 10.1126/science.1165942.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1165942</ArticleId><ArticleId IdType="pmc">PMC4516382</ArticleId><ArticleId IdType="pubmed">19251628</ArticleId></ArticleIdList></Reference><Reference><Citation>Klar J, et al. Welander distal myopathy caused by an ancient founder mutation in TIA1 associated with perturbed splicing. Hum. Mutat. 2013;34:572&#x2013;577.</Citation><ArticleIdList><ArticleId IdType="pubmed">23348830</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie IR, et al. TIA1 mutations in amyotrophic lateral sclerosis and frontotemporal dementia promote phase separation and alter stress granule dynamics. Neuron. 2017;95:808&#x2013;816.e9. doi: 10.1016/j.neuron.2017.07.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2017.07.025</ArticleId><ArticleId IdType="pmc">PMC5576574</ArticleId><ArticleId IdType="pubmed">28817800</ArticleId></ArticleIdList></Reference><Reference><Citation>Benatar M, et al. Motor neuron involvement in multisystem proteinopathy: implications for ALS. Neurology. 2013;80:1874&#x2013;1880. doi: 10.1212/WNL.0b013e3182929fc3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3182929fc3</ArticleId><ArticleId IdType="pmc">PMC3908355</ArticleId><ArticleId IdType="pubmed">23635965</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathieu C, Pappu RV, Taylor JP. Beyond aggregation: pathological phase transitions in neurodegenerative disease. Science. 2020;370:56&#x2013;60. doi: 10.1126/science.abb8032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abb8032</ArticleId><ArticleId IdType="pmc">PMC8359821</ArticleId><ArticleId IdType="pubmed">33004511</ArticleId></ArticleIdList></Reference><Reference><Citation>Nedelsky, N. B. &amp; Taylor, J. P. Pathological phase transitions in ALS-FTD impair dynamic RNA-protein granules. RNA28, 97&#x2013;113 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8675280</ArticleId><ArticleId IdType="pubmed">34706979</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryan VH, et al. Mechanistic view of hnRNPA2 low-complexity domain structure, interactions, and phase separation altered by mutation and arginine methylation. Mol. Cell. 2018;69:465&#x2013;479.e7. doi: 10.1016/j.molcel.2017.12.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2017.12.022</ArticleId><ArticleId IdType="pmc">PMC5801700</ArticleId><ArticleId IdType="pubmed">29358076</ArticleId></ArticleIdList></Reference><Reference><Citation>Pesiridis GS, Lee VM, Trojanowski JQ. Mutations in TDP-43 link glycine-rich domain functions to amyotrophic lateral sclerosis. Hum. Mol. Genet. 2009;18:R156&#x2013;R162. doi: 10.1093/hmg/ddp303.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddp303</ArticleId><ArticleId IdType="pmc">PMC2758707</ArticleId><ArticleId IdType="pubmed">19808791</ArticleId></ArticleIdList></Reference><Reference><Citation>Shang Y, Huang EJ. Mechanisms of FUS mutations in familial amyotrophic lateral sclerosis. Brain Res. 2016;1647:65&#x2013;78. doi: 10.1016/j.brainres.2016.03.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2016.03.036</ArticleId><ArticleId IdType="pmc">PMC5003642</ArticleId><ArticleId IdType="pubmed">27033831</ArticleId></ArticleIdList></Reference><Reference><Citation>Molliex A, et al. Phase separation by low complexity domains promotes stress granule assembly and drives pathological fibrillization. Cell. 2015;163:123&#x2013;133. doi: 10.1016/j.cell.2015.09.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2015.09.015</ArticleId><ArticleId IdType="pmc">PMC5149108</ArticleId><ArticleId IdType="pubmed">26406374</ArticleId></ArticleIdList></Reference><Reference><Citation>Tada M, et al. Matrin 3 Is a component of neuronal cytoplasmic inclusions of motor neurons in sporadic amyotrophic lateral sclerosis. Am. J. Pathol. 2018;188:507&#x2013;514. doi: 10.1016/j.ajpath.2017.10.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajpath.2017.10.007</ArticleId><ArticleId IdType="pubmed">29128563</ArticleId></ArticleIdList></Reference><Reference><Citation>Batlle C, et al. hnRNPDL phase separation is regulated by alternative splicing and disease-causing mutations accelerate its aggregation. Cell Rep. 2020;30:1117&#x2013;1128.e5. doi: 10.1016/j.celrep.2019.12.080.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2019.12.080</ArticleId><ArticleId IdType="pmc">PMC6996132</ArticleId><ArticleId IdType="pubmed">31995753</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo W, et al. An ALS-associated mutation affecting TDP-43 enhances protein aggregation, fibril formation and neurotoxicity. Nat. Struct. Mol. Biol. 2011;18:822&#x2013;830. doi: 10.1038/nsmb.2053.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nsmb.2053</ArticleId><ArticleId IdType="pmc">PMC3357956</ArticleId><ArticleId IdType="pubmed">21666678</ArticleId></ArticleIdList></Reference><Reference><Citation>Trollet, C. et al. Oculopharyngeal muscular dystrophy. In GeneReviews((R)) (eds. Adam, M. P. et al.) (University of Washington, Seattle, WA, 1993).</Citation><ArticleIdList><ArticleId IdType="pubmed">20301305</ArticleId></ArticleIdList></Reference><Reference><Citation>Karczewski KJ, et al. The mutational constraint spectrum quantified from variation in 141,456 humans. Nature. 2020;581:434&#x2013;443. doi: 10.1038/s41586-020-2308-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2308-7</ArticleId><ArticleId IdType="pmc">PMC7334197</ArticleId><ArticleId IdType="pubmed">32461654</ArticleId></ArticleIdList></Reference><Reference><Citation>Siomi H, Dreyfuss G. A nuclear localization domain in the hnRNP A1 protein. J. Cell Biol. 1995;129:551&#x2013;560. doi: 10.1083/jcb.129.3.551.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.129.3.551</ArticleId><ArticleId IdType="pmc">PMC2120450</ArticleId><ArticleId IdType="pubmed">7730395</ArticleId></ArticleIdList></Reference><Reference><Citation>Michael WM, Choi M, Dreyfuss G. A nuclear export signal in hnRNP A1: a signal-mediated, temperature-dependent nuclear protein export pathway. Cell. 1995;83:415&#x2013;422. doi: 10.1016/0092-8674(95)90119-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0092-8674(95)90119-1</ArticleId><ArticleId IdType="pubmed">8521471</ArticleId></ArticleIdList></Reference><Reference><Citation>Pollard VW, et al. A novel receptor-mediated nuclear protein import pathway. Cell. 1996;86:985&#x2013;994. doi: 10.1016/S0092-8674(00)80173-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0092-8674(00)80173-7</ArticleId><ArticleId IdType="pubmed">8808633</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee BJ, et al. Rules for nuclear localization sequence recognition by karyopherin beta 2. Cell. 2006;126:543&#x2013;558. doi: 10.1016/j.cell.2006.05.049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2006.05.049</ArticleId><ArticleId IdType="pmc">PMC3442361</ArticleId><ArticleId IdType="pubmed">16901787</ArticleId></ArticleIdList></Reference><Reference><Citation>Allemand E, et al. Regulation of heterogenous nuclear ribonucleoprotein A1 transport by phosphorylation in cells stressed by osmotic shock. Proc. Natl Acad. Sci. USA. 2005;102:3605&#x2013;3610. doi: 10.1073/pnas.0409889102.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0409889102</ArticleId><ArticleId IdType="pmc">PMC553333</ArticleId><ArticleId IdType="pubmed">15738418</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossi AM, Taylor CW. Analysis of protein-ligand interactions by fluorescence polarization. Nat. Protoc. 2011;6:365&#x2013;387. doi: 10.1038/nprot.2011.305.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nprot.2011.305</ArticleId><ArticleId IdType="pmc">PMC3160472</ArticleId><ArticleId IdType="pubmed">21372817</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang ZC, Chook YM. Structural and energetic basis of ALS-causing mutations in the atypical proline-tyrosine nuclear localization signal of the Fused in Sarcoma protein (FUS) Proc. Natl Acad. Sci. USA. 2012;109:12017&#x2013;12021. doi: 10.1073/pnas.1207247109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1207247109</ArticleId><ArticleId IdType="pmc">PMC3409756</ArticleId><ArticleId IdType="pubmed">22778397</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalderon D, Richardson WD, Markham AF, Smith AE. Sequence requirements for nuclear location of simian virus 40 large-T antigen. Nature. 1984;311:33&#x2013;38. doi: 10.1038/311033a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/311033a0</ArticleId><ArticleId IdType="pubmed">6088992</ArticleId></ArticleIdList></Reference><Reference><Citation>Duffy JB. GAL4 system in Drosophila: a fly geneticist&#x2019;s Swiss army knife. Genesis. 2002;34:1&#x2013;15. doi: 10.1002/gene.10150.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/gene.10150</ArticleId><ArticleId IdType="pubmed">12324939</ArticleId></ArticleIdList></Reference><Reference><Citation>Freibaum BD, et al. GGGGCC repeat expansion in C9orf72 compromises nucleocytoplasmic transport. Nature. 2015;525:129&#x2013;133. doi: 10.1038/nature14974.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature14974</ArticleId><ArticleId IdType="pmc">PMC4631399</ArticleId><ArticleId IdType="pubmed">26308899</ArticleId></ArticleIdList></Reference><Reference><Citation>Li S, et al. Genetic interaction of hnRNPA2B1 and DNAJB6 in a Drosophila model of multisystem proteinopathy. Hum. Mol. Genet. 2016;25:936&#x2013;950. doi: 10.1093/hmg/ddv627.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddv627</ArticleId><ArticleId IdType="pmc">PMC4754048</ArticleId><ArticleId IdType="pubmed">26744327</ArticleId></ArticleIdList></Reference><Reference><Citation>Prayson RA, Cohen ML. Ubiquitin immunostaining and inclusion body myositis: study of 30 patients with inclusion body myositis. Hum. Pathol. 1997;28:887&#x2013;892. doi: 10.1016/S0046-8177(97)90002-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0046-8177(97)90002-2</ArticleId><ArticleId IdType="pubmed">9269823</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinsson T, et al. Autosomal dominant myopathy: missense mutation (Glu-706&#x2013;&gt;Lys) in the myosin heavy chain IIa gene. Proc. Natl Acad. Sci. USA. 2000;97:14614&#x2013;14619. doi: 10.1073/pnas.250289597.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.250289597</ArticleId><ArticleId IdType="pmc">PMC18967</ArticleId><ArticleId IdType="pubmed">11114175</ArticleId></ArticleIdList></Reference><Reference><Citation>Izumi R, et al. Isolated inclusion body myopathy caused by a multisystem proteinopathy-linked hnRNPA1 mutation. Neurol. Genet. 2015;1:e23. doi: 10.1212/NXG.0000000000000023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXG.0000000000000023</ArticleId><ArticleId IdType="pmc">PMC4809462</ArticleId><ArticleId IdType="pubmed">27066560</ArticleId></ArticleIdList></Reference><Reference><Citation>Hackman P, et al. Welander distal myopathy is caused by a mutation in the RNA-binding protein TIA1. Ann. Neurol. 2013;73:500&#x2013;509. doi: 10.1002/ana.23831.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.23831</ArticleId><ArticleId IdType="pubmed">23401021</ArticleId></ArticleIdList></Reference><Reference><Citation>Brais B, et al. Short GCG expansions in the PABP2 gene cause oculopharyngeal muscular dystrophy. Nat. Genet. 1998;18:164&#x2013;167. doi: 10.1038/ng0298-164.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng0298-164</ArticleId><ArticleId IdType="pubmed">9462747</ArticleId></ArticleIdList></Reference><Reference><Citation>Seelen M, et al. No mutations in hnRNPA1 and hnRNPA2B1 in Dutch patients with amyotrophic lateral sclerosis, frontotemporal dementia, and inclusion body myopathy. Neurobiol. Aging. 2014;35:1956e9&#x2013;1956e11. doi: 10.1016/j.neurobiolaging.2014.01.152.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2014.01.152</ArticleId><ArticleId IdType="pubmed">24612671</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Ber I, et al. hnRNPA2B1 and hnRNPA1 mutations are rare in patients with &#x201c;multisystem proteinopathy&#x201d; and frontotemporal lobar degeneration phenotypes. Neurobiol. Aging. 2014;35:934 e5-6.</Citation><ArticleIdList><ArticleId IdType="pubmed">24119545</ArticleId></ArticleIdList></Reference><Reference><Citation>Calini D, et al. Analysis of hnRNPA1, A2/B1, and A3 genes in patients with amyotrophic lateral sclerosis. Neurobiol. Aging. 2013;34:2695 e11-2. doi: 10.1016/j.neurobiolaging.2013.05.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2013.05.025</ArticleId><ArticleId IdType="pmc">PMC6591723</ArticleId><ArticleId IdType="pubmed">23827524</ArticleId></ArticleIdList></Reference><Reference><Citation>Gasset-Rosa F, et al. Cytoplasmic TDP-43 de-mixing independent of stress granules drives inhibition of nuclear import, loss of nuclear TDP-43, and cell death. Neuron. 2019;102:339&#x2013;357.e7. doi: 10.1016/j.neuron.2019.02.038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2019.02.038</ArticleId><ArticleId IdType="pmc">PMC6548321</ArticleId><ArticleId IdType="pubmed">30853299</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshizawa T, et al. Nuclear import receptor inhibits phase separation of FUS through binding to multiple sites. Cell. 2018;173:693&#x2013;705.e22. doi: 10.1016/j.cell.2018.03.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2018.03.003</ArticleId><ArticleId IdType="pmc">PMC6234985</ArticleId><ArticleId IdType="pubmed">29677513</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo L, et al. Nuclear-import receptors reverse aberrant phase transitions of RNA-binding proteins with prion-like domains. Cell. 2018;173:677&#x2013;692.e20. doi: 10.1016/j.cell.2018.03.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2018.03.002</ArticleId><ArticleId IdType="pmc">PMC5911940</ArticleId><ArticleId IdType="pubmed">29677512</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee KH, et al. C9orf72 dipeptide repeats impair the assembly, dynamics, and function of membrane-less organelles. Cell. 2016;167:774&#x2013;788.e17. doi: 10.1016/j.cell.2016.10.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2016.10.002</ArticleId><ArticleId IdType="pmc">PMC5079111</ArticleId><ArticleId IdType="pubmed">27768896</ArticleId></ArticleIdList></Reference><Reference><Citation>Boeynaems S, et al. Phase separation of C9orf72 dipeptide repeats perturbs stress granule dynamics. Mol. Cell. 2017;65:1044&#x2013;1055.e5. doi: 10.1016/j.molcel.2017.02.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2017.02.013</ArticleId><ArticleId IdType="pmc">PMC5364369</ArticleId><ArticleId IdType="pubmed">28306503</ArticleId></ArticleIdList></Reference><Reference><Citation>Gwon, Y. et al. Ubiquitination of G3BP1 mediates stress granule disassembly in a context-specific manner. Science372, eabf6548 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8574224</ArticleId><ArticleId IdType="pubmed">34739333</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Deerlin VM, et al. TARDBP mutations in amyotrophic lateral sclerosis with TDP-43 neuropathology: a genetic and histopathological analysis. Lancet Neurol. 2008;7:409&#x2013;416. doi: 10.1016/S1474-4422(08)70071-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(08)70071-1</ArticleId><ArticleId IdType="pmc">PMC3546119</ArticleId><ArticleId IdType="pubmed">18396105</ArticleId></ArticleIdList></Reference><Reference><Citation>Vogler TO, et al. TDP-43 and RNA form amyloid-like myo-granules in regenerating muscle. Nature. 2018;563:508&#x2013;513. doi: 10.1038/s41586-018-0665-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-018-0665-2</ArticleId><ArticleId IdType="pmc">PMC6324568</ArticleId><ArticleId IdType="pubmed">30464263</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergeron D, Pal G, Beaulieu YB, Chabot B, Bachand F. Regulated intron retention and nuclear pre-mRNA decay contribute to PABPN1 autoregulation. Mol. Cell Biol. 2015;35:2503&#x2013;2517. doi: 10.1128/MCB.00070-15.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.00070-15</ArticleId><ArticleId IdType="pmc">PMC4475927</ArticleId><ArticleId IdType="pubmed">25963658</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanaka AJ, et al. Mutations in SPATA5 are associated with microcephaly, intellectual disability, seizures, and hearing loss. Am. J. Hum. Genet. 2015;97:457&#x2013;464. doi: 10.1016/j.ajhg.2015.07.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajhg.2015.07.014</ArticleId><ArticleId IdType="pmc">PMC4564988</ArticleId><ArticleId IdType="pubmed">26299366</ArticleId></ArticleIdList></Reference><Reference><Citation>Topf A, et al. Sequential targeted exome sequencing of 1001 patients affected by unexplained limb-girdle weakness. Genet. Med. 2020;22:1478&#x2013;1488. doi: 10.1038/s41436-020-0840-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41436-020-0840-3</ArticleId><ArticleId IdType="pmc">PMC7462745</ArticleId><ArticleId IdType="pubmed">32528171</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashton JJ, et al. Identification of variants in genes associated with single-gene inflammatory bowel disease by whole-exome sequencing. Inflamm. Bowel Dis. 2016;22:2317&#x2013;2327. doi: 10.1097/MIB.0000000000000890.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MIB.0000000000000890</ArticleId><ArticleId IdType="pubmed">27537055</ArticleId></ArticleIdList></Reference><Reference><Citation>Schartner V, et al. Dihydropyridine receptor (DHPR, CACNA1S) congenital myopathy. Acta Neuropathol. 2017;133:517&#x2013;533. doi: 10.1007/s00401-016-1656-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-016-1656-8</ArticleId><ArticleId IdType="pubmed">28012042</ArticleId></ArticleIdList></Reference><Reference><Citation>Macchione F, et al. Multiple acyl-COA dehydrogenase deficiency in elderly carriers. J. Neurol. 2020;267:1414&#x2013;1419. doi: 10.1007/s00415-020-09729-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-020-09729-z</ArticleId><ArticleId IdType="pubmed">31997039</ArticleId></ArticleIdList></Reference><Reference><Citation>French CE, et al. Whole genome sequencing reveals that genetic conditions are frequent in intensively ill children. Intensive Care Med. 2019;45:627&#x2013;636. doi: 10.1007/s00134-019-05552-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-019-05552-x</ArticleId><ArticleId IdType="pmc">PMC6483967</ArticleId><ArticleId IdType="pubmed">30847515</ArticleId></ArticleIdList></Reference><Reference><Citation>Iida, A. et al. A novel PAK3 pathogenic variant identified in two siblings from a Japanese family with X-linked intellectual disability: case report and review of the literature. Cold Spring Harb Mol Case Stud.5, a003988 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6913141</ArticleId><ArticleId IdType="pubmed">31444167</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang ZC, Satterly N, Fontoura BM, Chook YM. Evolutionary development of redundant nuclear localization signals in the mRNA export factor NXF1. Mol. Biol. Cell. 2011;22:4657&#x2013;4668. doi: 10.1091/mbc.e11-03-0222.</Citation><ArticleIdList><ArticleId IdType="doi">10.1091/mbc.e11-03-0222</ArticleId><ArticleId IdType="pmc">PMC3226482</ArticleId><ArticleId IdType="pubmed">21965294</ArticleId></ArticleIdList></Reference><Reference><Citation>Cupo RR, Shorter J. Expression and purification of recombinant Skd3 (human ClpB) protein and tobacco Etch virus (TEV) protease from Escherichia coli. Bio Protoc. 2020;10:e3858. doi: 10.21769/BioProtoc.3858.</Citation><ArticleIdList><ArticleId IdType="doi">10.21769/BioProtoc.3858</ArticleId><ArticleId IdType="pmc">PMC7842574</ArticleId><ArticleId IdType="pubmed">33659495</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>